SURAKSHA — Suraksha Diagnostic Income Statement
0.000.00%
- IN₹14.41bn
- IN₹15.13bn
- IN₹2.52bn
- 65
- 11
- 48
- 33
Annual income statement for Suraksha Diagnostic, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 2,232 | 1,901 | 2,187 | 2,521 |
| Cost of Revenue | ||||
| Gross Profit | 1,573 | 1,560 | 1,846 | 2,153 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 1,875 | 1,754 | 1,799 | 2,059 |
| Operating Profit | 357 | 147 | 388 | 462 |
| Gain / Loss on Sale of Assets | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 280 | 67.5 | 315 | 414 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 208 | 60.6 | 231 | 310 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | 208 | 65.2 | 236 | 318 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 208 | 65.2 | 236 | 318 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 4.2 | 1.67 | 4.95 | 6.15 |
| Dividends per Share |